Výsledky vyhledávání - "Françoise, Ponci"

Improved Efficiency of a Salmonella -Based Vaccine against Human Papillomavirus Type 16 Virus-Like Particles Achieved by Using a Codon-Optimized Version of L1

Autor: Pierre De Grandi, Françoise Ponci, Martine Bobst, Denise Nardelli-Haefliger, David Baud

Publikováno v: Journal of Virology. 78:12901-12909

Cervical cancer results from cervical infection by human papillomaviruses (HPVs), especially HPV16. An effective vaccine against these HPVs is expected to have a dramatic impact on the incidence of this cancer and its precursor lesions. The leading c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd5959b2cfeb5f6f7b376a669ab22de
https://doi.org/10.1128/jvi.78.23.12901-12909.2004

Zobrazit plný text záznamu

Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever

Autor: John T. Schiller, Martine Bobst, Denise Nardelli-Haefliger, Françoise Ponci, Nathalie Zosso, David Baud, Susana Yuk-Ying Pang, Dominique Fraillery

Publikováno v: Clinical and vaccine immunology : CVI. 14(10)

Human papillomavirus (HPV) vaccines based on L1 virus-like particles (VLPs) can prevent HPV-induced genital neoplasias, the precursors of cervical cancer. However, most cervical cancers occur in developing countries, where the implementation of expen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6658eb102699c6308878fab5b5cfcf
https://pubmed.ncbi.nlm.nih.gov/17687110

Zobrazit plný text záznamu

Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants

Autor: Denise Nardelli-Haefliger, Rinaldo Zurbriggen, Véronique Revaz, Françoise Ponci, Christian Moser, Martine Bobst, John T. Schiller

Publikováno v: Antiviral research. 76(1)

Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. Intramuscular administrations of HPV16 virus-like particle (VLP) vaccines have been shown to induce strong neutralizing antibody responses and protect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb78556b7d421ef249bffd217c7aea59
https://pubmed.ncbi.nlm.nih.gov/17617476

Zobrazit plný text záznamu

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine

Autor: John T. Schiller, Pierre De Grandi, Floriana Lurati, Douglas R. Lowy, Denise Nardelli-Haefliger, Françoise Ponci, François Spertini, D. Wirthner

Publikováno v: Vaccine. 23(28)

Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. Previous studies have shown that intramuscular vaccination of women with an HPV16 virus-like particle (VLP) vaccine induced a strong IgG response and p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b91cf3afb8537fd9a86829da837cca4c
https://pubmed.ncbi.nlm.nih.gov/15882523

Zobrazit plný text záznamu

Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium

Autor: Martine Bobst, Véronique Revaz, Roy Curtiss, Pierre De Grandi, Jalil Benyacoub, Denise Nardelli-Haefliger, David Baud, Menno Kok, Françoise Ponci

Publikováno v: Infection and immunity. 72(2)

RecombinantSalmonellastrains have been widely used to deliver heterologous antigens and induce immune responses in vaccinated animals and humans. It remains to be established, however, how these bacteria mount an immune response; this has prevented t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a71420607b7e8dce0404e6396b7ac2
https://pubmed.ncbi.nlm.nih.gov/14742517

Zobrazit plný text záznamu

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

Autor: Denise, Nardelli-Haefliger, Daniel, Wirthner, John T, Schiller, Douglas R, Lowy, Allan, Hildesheim, Françoise, Ponci, Pierre, De Grandi

Publikováno v: Journal of the National Cancer Institute, vol. 95, no. 15, pp. 1128-37

Background: In early-phase trials, a human papillomavirus 16 (HPV16) virus-like particle (VLP) vaccine has been shown to be well tolerated, immunogenic, and protective against HPV16 in women, most of whom were taking oral contraceptives. Previous stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f6fa51db747d7f4d1c3ca08797f5be
https://serval.unil.ch/notice/serval:BIB_BEEC4DDFA954

Zobrazit plný text záznamu

Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles

Autor: Françoise Ponci, Douglas R. Lowy, D. Wirthner, Pierre De Grandi, Allan Hildesheim, Denise Nardelli-Haefliger, John T. Schiller

Publikováno v: JNCI Journal of the National Cancer Institute. 96:412-413

Background In early-phase trials, a human papillomavirus 16 (HPV16) virus-like particle (VLP) vaccine has been shown to be well tolerated, immunogenic, and protective against HPV16 in women, most of whom were taking oral contraceptives. Previous stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::39e68f89b9648f17e4c5290cd3e6f99a
https://doi.org/10.1093/jnci/djh071

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání